Patrick Gillard
Overview
Explore the profile of Patrick Gillard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
685
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Esquenazi A, Bloudek L, Migliaccio-Walle K, Oliveri D, Tung A, Gillard P, et al.
J Rehabil Med
. 2023 Oct;
55:jrm11626.
PMID: 37902443
Background: Real-world data regarding the impact of onabotulinumtoxinA on healthcare resource utilization and costs for post-stroke spasticity are scarce. Objective: To compare differences in 12-month healthcare resource utilization and costs...
2.
Park T, Hansen R, Gillard P, Shah D, Ferguson W, Piccini J, et al.
J Med Econ
. 2023 Oct;
26(1):1417-1423.
PMID: 37801391
Background: Postoperative atrial fibrillation (POAF) is one of the most common complications following cardiac surgery. POAF is associated with increased hospitalization costs, but its long-term economic burden is not well...
3.
Schwedt T, Lee J, Knievel K, McVige J, Wang W, Wu Z, et al.
J Manag Care Spec Pharm
. 2023 Sep;
29(10):1119-1128.
PMID: 37776119
Chronic migraine (CM) is a common neurologic disorder that imposes substantial burden on payers, patients, and society. Low rates of persistence to oral migraine preventive medications have been previously documented;...
4.
McIntyre R, Higa S, Doan Q, Amari D, Mercer D, Gillard P, et al.
J Manag Care Spec Pharm
. 2023 Apr;
29(5):499-508.
PMID: 37121252
Schizophrenia imposes significant economic burden on patients, families, caregivers, and society. To our knowledge, place of care and associated costs of acute schizophrenia episodes have not been well characterized. To...
5.
McIntyre R, Bloudek L, Timmons J, Gillard P, Harrington A
Curr Med Res Opin
. 2023 Feb;
39(4):605-611.
PMID: 36776128
Introduction: Misdiagnosis of bipolar I disorder (BP-I) as major depressive disorder (MDD) leads to increased healthcare resource utilization and costs. The cost-effectiveness of the Rapid Mood Screener (RMS), a tool...
6.
Murray B, Miles-Thomas J, Park A, Nguyen V, Tung A, Gillard P, et al.
J Comp Eff Res
. 2023 Jan;
12(2):e220089.
PMID: 36655745
The cost-effectiveness of treatment options (anticholinergics, β3-adrenoceptor agonists, onabotulinumtoxinA, sacral nerve stimulation and percutaneous tibial stimulation [the latter two including new rechargeable neurostimulators]) for the management of overactive bladder (OAB)...
7.
Cutler A, Keyloun K, Higa S, Park J, Bonafede M, Gillard P, et al.
J Manag Care Spec Pharm
. 2022 Nov;
28(12):1335-1343.
PMID: 36427344
The economic burden of major depressive disorder (MDD) is substantial and increasing; however, the impact of key clinical events (eg, hospitalization, suicide attempt/ideation, and treatment changes) on health care resource...
8.
McIntyre R, Higa S, Doan Q, Amari D, Oliveri D, Gillard P, et al.
J Med Econ
. 2022 Sep;
25(1):1110-1117.
PMID: 36082506
Aims: To our knowledge, literature describing the place of care and associated costs during acute bipolar I disorder (BP-I) episodes is limited. We conducted a claims-based retrospective study to address...
9.
McIntyre R, Laliberte F, Germain G, MacKnight S, Gillard P, Harrington A
J Affect Disord
. 2022 Aug;
316:26-33.
PMID: 35952932
Background: Misdiagnosis of bipolar I disorder (BP-I) as major depressive disorder (MDD) is common. This study evaluated healthcare resource utilization (HRU) and costs among BP-I patients who were initially misdiagnosed...
10.
Jain R, Higa S, Keyloun K, Park J, Bonafede M, Tung A, et al.
Drugs Real World Outcomes
. 2022 Jun;
9(3):477-486.
PMID: 35771409
Background: Major depressive disorder, a highly prevalent mental health condition, can be challenging to treat. Objective: We aimed to characterize treatment patterns within and across multiple major depressive episodes in...